PLUS THERAPEUTICS, INC. — Director's Dealing 2024

Sep 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2024-09-11

Reporting Person: HEDRICK MARC H (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-11	Stock Option (Right to Buy)	$1.26	A	197595	Acquired	2034-09-11	Common Stock (197595)	Direct

Footnotes

F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.